• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy.

作者信息

Daraskevicius Justinas, Everatt Veronika, Vaitekenaite Vilmante, Ringeleviciute Ugne, Maneikis Kazimieras, Zucenka Andrius

机构信息

Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.

出版信息

Leuk Res. 2021 Dec;111:106692. doi: 10.1016/j.leukres.2021.106692. Epub 2021 Aug 21.

DOI:10.1016/j.leukres.2021.106692
PMID:34438121
Abstract
摘要

相似文献

1
Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy.
Leuk Res. 2021 Dec;111:106692. doi: 10.1016/j.leukres.2021.106692. Epub 2021 Aug 21.
2
Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax-based salvage therapies.接受 Venetoclax 为基础的挽救治疗后复发/难治性急性髓系白血病患者的结局。
Eur J Haematol. 2021 Jan;106(1):105-113. doi: 10.1111/ejh.13527. Epub 2020 Oct 27.
3
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.克拉屈滨加阿糖胞苷加维奈克拉治疗对维奈克拉加去甲基化药物难治或复发的急性髓系白血病
Haematologica. 2024 Aug 1;109(8):2706-2710. doi: 10.3324/haematol.2024.284962.
4
Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone.孕期难治性急性髓系白血病采用维奈克拉、大剂量阿糖胞苷和米托蒽醌治疗。
Br J Haematol. 2021 Jan;192(2):e60-e63. doi: 10.1111/bjh.17220. Epub 2020 Nov 21.
5
Ambulatory Hematopoietic Stem Cell Transplantation in Young Adults with Acute Myeloid Leukemia Treated with Venetoclax and Low Doses of Cytarabine: Report of Two Cases.年轻成人急性髓细胞白血病患者采用维奈托克联合小剂量阿糖胞苷行门诊造血干细胞移植：两例报告。
J Adolesc Young Adult Oncol. 2019 Aug;8(4):481-483. doi: 10.1089/jayao.2018.0137. Epub 2019 Mar 4.
6
Venetoclax-induced panniculitis in an acute myeloid leukemia patient.维奈托克诱发急性髓系白血病患者发生脂膜炎。
Ann Hematol. 2021 May;100(5):1333-1334. doi: 10.1007/s00277-020-04372-0. Epub 2021 Jan 13.
7
Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial.
Hematol Oncol. 2024 Jul;42(4):e3296. doi: 10.1002/hon.3296.
8
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351).接受去甲基化药物联合维奈克拉（HMA-Ven）或脂质体柔红霉素-阿糖胞苷（CPX-351）治疗的继发性急性髓系白血病的治疗结果
Am J Hematol. 2021 Jun 1;96(6):E196-E200. doi: 10.1002/ajh.26157. Epub 2021 Apr 8.
9
Optimizing venetoclax dose in combination with low intensive therapies in elderly patients with newly diagnosed acute myeloid leukemia: An exposure-response analysis.优化新型老年急性髓系白血病患者联合低强度治疗方案中的维奈托克剂量：暴露反应分析。
Hematol Oncol. 2019 Oct;37(4):464-473. doi: 10.1002/hon.2646. Epub 2019 Aug 2.
10
Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantation.维奈托克联合地西他滨可诱导造血干细胞移植后复发的急性髓系白血病完全缓解并伴有分子学反应。
Am J Hematol. 2019 Feb;94(2):E48-E50. doi: 10.1002/ajh.25352. Epub 2018 Nov 29.